Analysis-SpaceX’s slide below IPO price risks turning blockbuster IPO into confidence test

Rethinking recruitment and retention when the talent pool shrinks  Shawn Gibson, Chief Human Resources Officer at Infotech Research Group in London, Ont., says the population numbers from StatCan track with what he has already seen on the ground, particularly in a technology sector that has historically leaned on immigration to fill skills gaps.  “I think it’s something to be concerned about, definitely in a pool where many…

For the past two college-admission cycles, parents of college-bound teenagers who own small businesses or family farms have been treated shabbily. Back in 2024, the rules governing the federal financial aid system began harshly penalizing these parents. Tossing aside a decades-old practice, the Free Application for Federal Student Aid began including the net value of…

Stay up to date on all defensive stocks with Benzinga Pro, your go-to stock market research platform with real-time news and actionable insights. The S&P 500 index is regarded as the barometer of U.S. stock market performance. Composed of large-cap U.S. equities, the S&P 500 index is often used as a benchmark for professional and retail…

Basketball legend LeBron James has officially ended his eight-season run with the Los Angeles Lakers and the Golden State Warriors are reportedly the among the leading contenders to sign the four-time NBA champion for the 2026-2027 season. James’ future with the L.A.-based team was reported to be coming to an end at the end of…

Nearly 1 in 5 U.S. house hunters looked to relocate to a different metro area in the first quarter, up slightly from a year earlier.  Florida, Las Vegas and Phoenix are the most popular destinations, with many movers chasing affordability and sunshine.  New York, Seattle, Los Angeles and other expensive metros top the list of…

AstraZeneca‘s failed late-stage trial for Wainua was never expected to have a major financial impact on the company. Most analysts estimate the trial miss wiped just 2-4% from their valuation models. Yet the shares lost roughly twice that in a single session, suggesting the market reaction reflected more than just the loss of one drug,…